To determine the efficacy of adjuvant chemotherapy in patients with advanced head and neck squamous carcinoma, the National Cancer Insitute initiated a multi-institutional, prospective randomized trial termed the Head and Neck Contracts Program. Between 1978 and 1982,462 patients with resectable Sta
Induction Chemotherapy for Head and Neck Squamous Cell Carcinomas (SCCHN)
β Scribed by Merrill S. Kies
- Book ID
- 107531997
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 279 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1527-2729
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background The aim of this review was to discuss the role of altered fractionation and adjuvant chemotherapy for patients treated with definitive radiotherapy (RT) for head and neck squamous cell carcinoma (HNSCC). ## Methods This review explores the pertinent literature and discu
## Abstract Fiftyβone patients (32 previously untreated, 19 previously treated) with advanced squamous cell carcinoma of the head and neck received a single course of combination chemotherapy consisting of high dose __cis__βplatinum (DDP), bleomycin (Bleo), Β± high dose methotrexate (MTX). Thirtyβth